Brinter Highlighted as One of the 3D Bioprinting Companies for Tissue and Organ Transplants on Nanalyze

2022-01-11T13:26:54-08:00July 27th, 2021|Business, News|

The media and research firm Nanalyze has highlighted Brinter as [...]

Comments Off on Brinter Highlighted as One of the 3D Bioprinting Companies for Tissue and Organ Transplants on Nanalyze

In Vivo Assessment Of Articular Cartilage Repair With Nanoenabled COPLA® Scaffolds

2022-01-11T13:25:55-08:00July 20th, 2021|BioPrinting, Bioprinting applications, News, RESTORE project|

Brinter as a member of the RESTORE project is [...]

Comments Off on In Vivo Assessment Of Articular Cartilage Repair With Nanoenabled COPLA® Scaffolds

Brinter Raises €1.2M in Seed Funding to Accelerate 3D Printing Bioscience Research and Manufacturing for Uses That Range from Personalized Drugs to Human Spare Parts

2022-01-11T13:05:41-08:00June 11th, 2021|Business, Featured, News|

Turku, Finland (June 10th, 2021) Brinter announces the successful [...]

Comments Off on Brinter Raises €1.2M in Seed Funding to Accelerate 3D Printing Bioscience Research and Manufacturing for Uses That Range from Personalized Drugs to Human Spare Parts

3D Printing of Industrial, Pharmaceutical and Other Materials Using Granulate Printing (GP) Process

2022-01-11T12:56:53-08:00June 1st, 2021|Bioprinting modules, News|

Brinter has been developing the granulate-based multi-material 3D printing [...]

Comments Off on 3D Printing of Industrial, Pharmaceutical and Other Materials Using Granulate Printing (GP) Process

Title

Go to Top